Epsamon en es it fr

Epsamon Brand names, Epsamon Analogs

Epsamon Brand Names Mixture

  • No information avaliable

Epsamon Chemical_Formula


Epsamon RX_link


Epsamon fda sheet

Epsamon FDA

Epsamon msds (material safety sheet)

Epsamon MSDS

Epsamon Synthesis Reference

No information avaliable

Epsamon Molecular Weight

131.173 g/mol

Epsamon Melting Point

205 oC

Epsamon H2O Solubility

5.05E+005 mg/L

Epsamon State


Epsamon LogP


Epsamon Dosage Forms

Solution for injection (containing 250 mg/mL of aminocaproic acid) and tablets (500, 1000mg)

Epsamon Indication

For use in the treatment of excessive postoperative bleeding.

Epsamon Pharmacology

Aminocaproic acid works as an antifibrinolytic. It is a derivative of the amino acid lysine. The fibrinolysis-inhibitory effects of aminocaproic acid appear to be exerted principally via inhibition of plasminogen activators and to a lesser degree through antiplasmin activity.

Epsamon Absorption

Absorbed rapidly following oral administration. In adults, oral absorption appears to be a zero-order process with an absorption rate of 5.2 g/hr. The mean lag time in absorption is 10 minutes. After a single oral dose of 5 g, absorption was complete (F=1).

Epsamon side effects and Toxicity

A few cases of acute overdosage with intravenous administration have been reported. The effects have ranged from no reaction to transient hypotension to severe acute renal failure leading to death. The intravenous and oral LD50 were 3.0 and 12.0 g/kg respectively in the mouse and 3.2 and 16.4 g/kg respectively in the rat. An intravenous infusion dose of 2.3 g/kg was lethal in the dog.

Epsamon Patient Information

Epsamon Organisms Affected

Humans and other mammals